Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.3000
-0.0342 (-10.23%)
At close: Sep 18, 2026
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $12.24 million as of September 18, 2026. Its market cap has decreased by -88.09% in one year.
Market Cap
12.24M
Enterprise Value
3.19M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.30
ChartMarket Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 12.24M, a decrease of -92.59%. That is a compound annual growth rate of -38.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 12.24M | -70.51% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 19.42M |
| Finch Therapeutics Group | 16.62M |
| Inhibitor Therapeutics | 15.45M |
| Synlogic | 14.58M |
| ZIVO Bioscience | 13.29M |
| Zeo ScientifiX | 10.82M |
| Oncotelic Therapeutics | 10.71M |
| Brainstorm Cell Therapeutics | 9.93M |